Bank of Montreal’s Sienna Biopharmaceuticals, Inc. SNNA Stock Holding History

Bank of Montreal’s Portfolio SNNA Stock Details SNNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-20	Closed	–	–	5109
2019 Q3	$0	Sell	20 -633	-97%	-$429	﹤0.01%	5131
2019 Q2	$1K	Sell	653 -1,242	-66%	-$1.94K	﹤0.01%	4819
2019 Q1	$4K	Buy	1,895 +1,690	+824%	+$4.58K	﹤0.01%	4086
2018 Q4	$0	Buy	205 +99	+93%	+$873	﹤0.01%	4959
2018 Q3	$2K	Sell	106 -138	-57%	-$2.19K	﹤0.01%	4458
2018 Q2	$4K	Buy	244 +109	+81%	+$1.85K	﹤0.01%	4216
2018 Q1	$3K	Buy	+135	New	+$2.36K	﹤0.01%	4023

Other funds holding SNNA

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Private Ocean San Rafael, California $1.13B AUM 11.01% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of Montreal's SNNA Position: Q4 2019 in Review

Bank of Montreal sold out of Sienna Biopharmaceuticals, Inc. (SNNA) in Q4 2019, closing a stake of 20 shares.

Bank of Montreal first reported a position in SNNA in Q1 2018 and held it in 7 quarters. The position peaked at $4K in Q1 2019. 4 funds tracked by Wall St. Rank hold SNNA as of Q4 2019.

Bank of Montreal reported no remaining Sienna Biopharmaceuticals, Inc. position as of Q4 2019 after selling out during the quarter.
Bank of Montreal sold 20 Sienna Biopharmaceuticals, Inc. shares in Q4 2019.
Bank of Montreal first reported a position in Sienna Biopharmaceuticals, Inc. in Q1 2018 and held it in 7 quarters.
Bank of Montreal's Sienna Biopharmaceuticals, Inc. position peaked at $4K in Q1 2019.
4 funds tracked by Wall St. Rank held Sienna Biopharmaceuticals, Inc. as of Q4 2019.

Based on Bank of Montreal's 13F filing for Q4 2019, filed 10 Feb 2020.